Polish Black Pearls VC makes an exit from Nomi Biotech Corporation

The Gdańsk-based Black Pearls VC fund has made an exit from Nomi Biotech Corporation. The fund was the first investor in the company and supported it for three years.

  • Black Pearls VC is a Gdańsk-based fund with a focus on deeptech startups working across various sectors within globally-relevant markets. It has a successful track record of investments in areas such as digital health, enterprise software, fintech, and others.
  • The fund invests during seed to Series A rounds, with an average tickets ranging from €100,000 to €1 million. Its most recent investments include a €1 million seed round for Surveily and a €8.5 million round for Autenti.
  • Nomi Biotech Corporation is a Polish-Japanese biotechnology company. It specializes in selecting, researching, and manufacturing proprietary and clinically potent nutraceutical formulations. Possibly, the solution can achieve certain physiological benefits.
  • Thanks to the fund’s support, Nomi Biotech was able to carry out the R&D process, commercialize its products, and generate substantial revenue. The company also announced a closing of its pre-A investment round with an unnamed, private chemicals industry player.

Black Pearls VC is included in our Top 25 most active Polish VC funds 2022 ranking. You can read about it here, under the 19th place.